IM

Ishender Mohan

Active Director Director DIN 06701429
DIN 06701429 First appointment Oct 2013 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 8 active board seats
Total affiliations 8 Since Oct 2013
Shareholding value •••• Premium profile

About Ishender Mohan

Data last updated:

Ishender Mohan is a Director at Monark Biocare Private Limited (since 2013), Director at Fedley Healthcare Private Limited (since 2013) and Director at Pritus Healthcare Private Limited (since 2020), and holds 5 more current directorships. The companies operate in Pharma, Healthcare and Chemicals. The 7 current companies with reported revenue have a combined latest revenue of ₹23.42 Cr; the largest is Monark Biocare Private Limited at ₹12.18 Cr (FY 2023).

DIN 06701429
Primary Designation Director
Industry Pharma
First Appointment 04 Oct 2013
Oldest Company Age 14 yrs
Largest company Monark Biocare Private Limited · ₹12.18 Cr (FY 2023)
Combined revenue ₹23.42 Cr across 7 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Monark Biocare Private Limited U24232HR2011PTC044353
Director04 Oct 20132011₹12.18 Cr (FY 2023)Active
Fedley Healthcare Private Limited U24100HR2013PTC049177
Director05 Oct 20132013₹6.61 Cr (FY 2024)Active
Pritus Healthcare Private Limited U24290HR2020PTC087662
Director20 Jul 20202020₹3.52 Cr (FY 2025)Active
Oscorp Remedies Private Limited U24290CH2021PTC043838
Director09 Aug 20212021₹84.3 Lakh (FY 2025)Active
Director03 Dec 20202020₹19.6 Lakh (FY 2025)Active
Radhyam Herbals Private Limited U21003HR2024PTC125266
Director01 Oct 20242024₹7.4 Lakh (FY 2025)Active
Semlon Remedies Private Limited U24290HR2022PTC100698
Director20 Jan 20222022₹32,420 (FY 2024)Active
Director10 May 20242024Active

Directorship timeline

Open interactive timeline →
Fedley Healthcare Private Limited
Monark Biocare Private Limited
Oscorp Remedies Private Limited
Pritus Healthcare Private Limited
Premium access

Shareholding and investment profile for Ishender Mohan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ishender Mohan

Ishender Mohan currently holds 8 directorships: Monark Biocare Private Limited (Director, since 04 Oct 2013, revenue ₹12.18 Cr (FY 2023)); Fedley Healthcare Private Limited (Director, since 05 Oct 2013, revenue ₹6.61 Cr (FY 2024)); Pritus Healthcare Private Limited (Director, since 20 Jul 2020, revenue ₹3.52 Cr (FY 2025)); Oscorp Remedies Private Limited (Director, since 09 Aug 2021, revenue ₹84.3 Lakh (FY 2025)); Alrosa Pharmaceuticals Private Limited (Director, since 03 Dec 2020, revenue ₹19.6 Lakh (FY 2025)); and 3 more.

Ishender Mohan was first appointed on 04 Oct 2013 as Director at Monark Biocare Private Limited. The most recent appointment on record is 01 Oct 2024 at Radhyam Herbals Private Limited.

The 7 current companies of Ishender Mohan that report revenue have a combined latest revenue of ₹23.42 Cr: Monark Biocare Private Limited ₹12.18 Cr (FY 2023); Fedley Healthcare Private Limited ₹6.61 Cr (FY 2024); Pritus Healthcare Private Limited ₹3.52 Cr (FY 2025); Oscorp Remedies Private Limited ₹84.3 Lakh (FY 2025); Alrosa Pharmaceuticals Private Limited ₹19.6 Lakh (FY 2025); and 2 more.

The current boards of Ishender Mohan's companies include Harishender Mohan (Monark Biocare Private Limited), Kashish Singal (Pritus Healthcare Private Limited), Divesh Gupta (Oscorp Remedies Private Limited), Abhishek Jain (Alrosa Pharmaceuticals Private Limited), Manu Sharma (Semlon Remedies Private Limited), Nishant Garg (Semlon Remedies Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available